Cargando…

miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma

BACKGROUND: As an oncogene, long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) can promote tumor metastasis. Hyperexpression of MALAT1 has been observed in many malignant tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of MALAT1 in HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Rong‐Jun, Fan, Jia‐Lin, Lin, Yu‐Cui, Pan, Yu‐Jia, Liu, Chi, Wan, Jia‐Hui, Wang, Wei, Jiang, Zheng‐Yuan, Zheng, Xiu‐Lan, Tang, Jie‐Bing, Yu, Xiao‐Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797582/
https://www.ncbi.nlm.nih.gov/pubmed/31466138
http://dx.doi.org/10.1002/cam4.2482
_version_ 1783459859714277376
author Cui, Rong‐Jun
Fan, Jia‐Lin
Lin, Yu‐Cui
Pan, Yu‐Jia
Liu, Chi
Wan, Jia‐Hui
Wang, Wei
Jiang, Zheng‐Yuan
Zheng, Xiu‐Lan
Tang, Jie‐Bing
Yu, Xiao‐Guang
author_facet Cui, Rong‐Jun
Fan, Jia‐Lin
Lin, Yu‐Cui
Pan, Yu‐Jia
Liu, Chi
Wan, Jia‐Hui
Wang, Wei
Jiang, Zheng‐Yuan
Zheng, Xiu‐Lan
Tang, Jie‐Bing
Yu, Xiao‐Guang
author_sort Cui, Rong‐Jun
collection PubMed
description BACKGROUND: As an oncogene, long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) can promote tumor metastasis. Hyperexpression of MALAT1 has been observed in many malignant tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of MALAT1 in HCC remain unclear. METHODS: Thirty human HCC and paracancerous tissue specimens were collected, and the human hepatoma cell lines Huh7 and HepG2 were cultured according to standard methods. MALAT1 and Snail family zinc finger (Slug) expression were measured by real‐time PCR, immunohistochemistry, and western blotting. Luciferase reporter assay and RNA immunoprecipitation (RIP) assay verified the direct interaction between miR‐124‐3p and Slug(SNAI2) or MALAT1. Wound healing and transwell assays were performed to examine invasion and migration, and a subcutaneous tumor model was established to measure tumor progression in vivo. RESULTS: MALAT1 expression was upregulated in HCC tissues and positively correlated with Slug expression. MALAT1 and miR‐124‐3p bind directly and reversibly to each other. MALAT1 silencing inhibited cell migration and invasion. miR‐124‐3p inhibited HCC metastasis by targeting Slug. CONCLUSIONS: MALAT1 regulates Slug through miR‐124‐3p, affecting HCC cell metastasis. Thus, the MALAT1/miR‐124‐3p/Slug axis plays an important role in HCC.
format Online
Article
Text
id pubmed-6797582
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67975822019-10-21 miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma Cui, Rong‐Jun Fan, Jia‐Lin Lin, Yu‐Cui Pan, Yu‐Jia Liu, Chi Wan, Jia‐Hui Wang, Wei Jiang, Zheng‐Yuan Zheng, Xiu‐Lan Tang, Jie‐Bing Yu, Xiao‐Guang Cancer Med Cancer Biology BACKGROUND: As an oncogene, long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) can promote tumor metastasis. Hyperexpression of MALAT1 has been observed in many malignant tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of MALAT1 in HCC remain unclear. METHODS: Thirty human HCC and paracancerous tissue specimens were collected, and the human hepatoma cell lines Huh7 and HepG2 were cultured according to standard methods. MALAT1 and Snail family zinc finger (Slug) expression were measured by real‐time PCR, immunohistochemistry, and western blotting. Luciferase reporter assay and RNA immunoprecipitation (RIP) assay verified the direct interaction between miR‐124‐3p and Slug(SNAI2) or MALAT1. Wound healing and transwell assays were performed to examine invasion and migration, and a subcutaneous tumor model was established to measure tumor progression in vivo. RESULTS: MALAT1 expression was upregulated in HCC tissues and positively correlated with Slug expression. MALAT1 and miR‐124‐3p bind directly and reversibly to each other. MALAT1 silencing inhibited cell migration and invasion. miR‐124‐3p inhibited HCC metastasis by targeting Slug. CONCLUSIONS: MALAT1 regulates Slug through miR‐124‐3p, affecting HCC cell metastasis. Thus, the MALAT1/miR‐124‐3p/Slug axis plays an important role in HCC. John Wiley and Sons Inc. 2019-08-29 /pmc/articles/PMC6797582/ /pubmed/31466138 http://dx.doi.org/10.1002/cam4.2482 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Cui, Rong‐Jun
Fan, Jia‐Lin
Lin, Yu‐Cui
Pan, Yu‐Jia
Liu, Chi
Wan, Jia‐Hui
Wang, Wei
Jiang, Zheng‐Yuan
Zheng, Xiu‐Lan
Tang, Jie‐Bing
Yu, Xiao‐Guang
miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
title miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
title_full miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
title_fullStr miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
title_full_unstemmed miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
title_short miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
title_sort mir‐124‐3p availability is antagonized by lncrna‐malat1 for slug‐induced tumor metastasis in hepatocellular carcinoma
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797582/
https://www.ncbi.nlm.nih.gov/pubmed/31466138
http://dx.doi.org/10.1002/cam4.2482
work_keys_str_mv AT cuirongjun mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT fanjialin mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT linyucui mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT panyujia mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT liuchi mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT wanjiahui mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT wangwei mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT jiangzhengyuan mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT zhengxiulan mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT tangjiebing mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma
AT yuxiaoguang mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma